[{"id":"116bdf7a-37b2-4fcf-ba03-fc222544ca83","acronym":"SRF114-101","url":"https://clinicaltrials.gov/study/NCT05635643","created_at":"2022-12-02T15:56:37.453Z","updated_at":"2025-02-25T16:46:24.062Z","phase":"Phase 1","brief_title":"Study of CHS-114 in Participants With Advanced Solid Tumors","source_id_and_acronym":"NCT05635643 - SRF114-101","lead_sponsor":"Coherus Biosciences, Inc.","biomarkers":" PD-L1","pipe":"","alterations":" ","tags":["PD-L1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tagmokitug (CHS-114)"],"overall_status":"Recruiting","enrollment":" Enrollment 47","initiation":"Initiation: 12/15/2022","start_date":" 12/15/2022","primary_txt":" Primary completion: 02/01/2026","primary_completion_date":" 02/01/2026","study_txt":" Completion: 02/01/2026","study_completion_date":" 02/01/2026","last_update_posted":"2025-02-05"}]